Target the fundamentals of cellular energy metabolism with BAM-15, a novel and selective mitochondrial protonophore uncoupler. This small-molecule compound is designed to safely and reversibly dissociate (uncouple) oxidative phosphorylation within mitochondria. By facilitating proton leakage across the inner mitochondrial membrane, it increases cellular oxygen consumption and basal energy expenditure without inhibiting the electron transport chain or generating excessive reactive oxygen species (ROS), distinguishing it from earlier uncouplers with significant toxicity concerns-1-5-8.
Supplied as a high-purity powder, BAM-15 serves as a pivotal research tool in metabolic disease studies. It is primarily investigated in preclinical models of obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) for its potential to reduce adiposity, improve glycemic control, and enhance metabolic flexibility-2-8. Researchers value its unique profile for exploring the therapeutic potential of mild mitochondrial uncoupling in regulating whole-body energy balance and addressing conditions rooted in metabolic dysfunction.
Choose BAM-15 for its contemporary design, targeted mechanism, and central role in advancing the science of metabolic regulation. It offers a sophisticated means to probe the critical link between mitochondrial bioenergetics and systemic metabolism in experimental settings.
